New MAHSC Sino-British health partnership
The Manchester Academic Health
Science Centre (MAHSC) has formed a partnership with the Peking
UniversityHealth Sciences Centre to establish an international
centre of excellence in genetic medicine.
The new Peking-Manchester Centre
for Genomic Medicine, announced by UK Chancellor George Osborne in
Beijing on Monday, will comprise three separate but interdependent
research facilities - the International Centre for Rare Diseases,
the Centre for Cancer Genetics, and the Joint Clinical Trials
MAHSC's involvement is being led by the Manchester Centre for
Genomic Medicine at Saint Mary's Hospital, an integrated centre
bringing together University of Manchester researchers and our
clinical services, to form a world leader in genetic and genomic
medicine for research into inherited diseases and delivery of
services to families with inherited disorders.
Speaking at Peking University, the Chancellor, who is in China
to promote UK business and encourage Chinese investors to choose
Britain, said: "I am delighted to announce here the establishment
of a new partnership between Peking University and Manchester
University in the UK with the creation of a new joint centre for
genomic medicine. Here, in the oldest and most prestigious medical
school in China, let us work together on the medicines of
"This partnership will, I hope, give even more of you the chance
to come to Britain and to study there. We already have 130,000
Chinese students, like you, studying in Britain - I want more of
you to come… There is no limit to the number of Chinese
[students] who can study in Britain."
Mike Deegan, Chief Executive of the Trust, said: "This is a
great indication of the quality of our clinical genetics services
within the Manchester Centre for Genomic Medicine. Working
collaboratively is key to improving health care; this partnership
will deliver cutting-edge translational research that will help our
clinicians develop innovative diagnostics and treatments to benefit
patients both in the UK and worldwide."
Dean and Vice-President of the University of Manchester's
Faculty of Medical and Human Sciences and Director of MAHSC,
Professor Ian Jacobs, who is participating in the government-led
visit, said: "This is an exciting partnership between MAHSC and our
colleagues in Beijing. It will lead to important health and
research benefits in the rapidly developing field of genetics to
benefit the people of both countries as well as having a global
impact. The planned work will draw on populations of up to 50
million individuals to harness next-generation genetic technology
for patient benefit.
"The joint venture will contribute to the further development of
the research strength of the Manchester Academic Health Science
Centre and advance Manchester's international reputation as a world
leader in personalised cancer medicine, while improving care and
diagnosis for many people here and in China."
The Peking University Health Sciences Centre (PUHSC) is the
oldest Western medical school in China, ranked first in the country
for research and training. As part of the collaboration, six senior
geneticists from the Manchester Centre for Genomic Medicine will
travel to Beijing this week to deliver a training course for more
than 300 health professionals and scientists at PUHSC.
Professor Graeme Black, Consultant in Genetic Medicine and
Director of the University of Manchester's Institute for Human
Development, added: "This joint venture comes at an exciting
moment. Genomic medicine promises to revolutionise
the understanding and delivery of care to patients across all
specialties of medicine. It is an opportunity to harness our
scientific discoveries for the benefit of the patients within our
two large populations."